9-month course of refractory anti-NMDA receptor encephalitis with initial negative markers: diagnostic and therapeutic challenges

Authors

Camilla Cascardo, Oakland University William Beaumont School of Medicine Medical Student
Alexander Ismail, Beaumont Health Resident
Francisco Davila, Beaumont Health
Nicole Marijanovich, Beaumont Health

Document Type

Conference Proceeding

Publication Date

5-13-2022

Abstract

Anti-NMDA receptor encephalitis is a progressively debilitating, clinically heterogeneous, frequently fatal disease caused by autoantibodies directed against the N-methyl-D-aspartate receptor that affects 1 in 1.5 million people each year. Risk of misdiagnosis or delayed treatment is high due to variable presentations and potential false negative results.

Comments

American College of Physicians Michigan Chapter Residents Day / Medical Students Day, May 13, 2022, Dearborn, MI.

Recommended Citation

Cascardo C, Ismail A, Marijanovich N, Davila F. 9-month course of refractory anti-NMDA receptor encephalitis with initial negative markers: diagnostic and therapeutic challenges. Abstract presented at: American College of Physicians Michigan Chapter Residents Day / Medical Students Day; 2022 May 13; Dearborn, MI.